VIVEK AGARWAL, MD., Senior Resident, Department of Psychiatry, Institute of Human Behaviour and Allied Sciences, Delhi.
Indian J Psychiatry. 2000 Jul;42(3):291-4.
Obsessive compulsive symptoms have been reported to occur in high proportion in schizophrenia. Presence of obsessive compulsive symptoms in schizophrenia has poor prognostic significance. Because of the antiobsessional effect of the fluoxetine, present study was undertaken as preliminary investigation in cases of schizophrenia with obsessive compulsive symptoms. We conducted an open trial of 12 weeks duration in which fluoxetine was added up to 80 mg to the maintenance neuroleptic medication of outpatients of schizophrenia with obsessive compulsive symptoms diagnosed by DSM-IV criteria. Five patients showed a significant reduction in scores of Positive and Negative Syndrome Scale, Yale Brown Obsessive Compulsive Scale and Clinical Global Impression Scale. Two patients did not show any response. Fluoxetine was well tolerated by all the patients. The positive findings of this preliminary investigation supports the further investigations of fluoxetine as potential treatment in the obsessive compulsive symptoms in schizophrenia.
强迫症症状在精神分裂症中发生率较高。精神分裂症中存在强迫症症状具有预后不良的意义。由于氟西汀具有抗强迫作用,因此进行了本研究,以初步调查伴有强迫症症状的精神分裂症患者。我们进行了为期 12 周的开放性试验,在其中将氟西汀添加到伴有强迫症症状的精神分裂症门诊患者的维持性神经安定药中,这些患者的强迫症症状符合 DSM-IV 标准。五名患者的阳性和阴性综合征量表、耶鲁-布朗强迫症量表和临床总体印象量表评分显著降低。两名患者没有任何反应。所有患者均能很好地耐受氟西汀。这项初步研究的阳性结果支持进一步研究氟西汀作为精神分裂症中强迫症症状的潜在治疗方法。